Eupafolin Suppresses P/Q-Type Ca2+ Channels to Inhibit Ca2+/Calmodulin-Dependent Protein Kinase II and Glutamate Release at Rat Cerebrocortical Nerve Terminals |
Chang, Anna
(School of Medicine, Fu Jen Catholic University)
Hung, Chi-Feng (School of Medicine, Fu Jen Catholic University) Hsieh, Pei-Wen (Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology) Ko, Horng-Huey (Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University) Wang, Su-Jane (School of Medicine, Fu Jen Catholic University) |
1 | Dunkley, P. R., Jarvie, P. E., Heath, J. W., Kidd, G. J. and Rostas, J. A. (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 372, 115-129. DOI |
2 | Grynkiewicz, G., Poenie, M. and Tsien, R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450. DOI |
3 | Lu, C. W., Lin, T. Y., Chiu, K. M., Lee, M. Y., Huang, J. H. and Wang, S. J. (2020) Silymarin inhibits glutamate release and prevents against kainic acid-induced excitotoxic injury in rats. Biomedicines 8, 486. DOI |
4 | Millan, C. and Sanchez-Prieto, J. (2002) Differential coupling of N- and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex. Neurosci. Lett. 330, 29-32. DOI |
5 | Nicholls, D. G. (1998) Presynaptic modulation of glutamate release. Prog. Brain Res. 116, 15-22. DOI |
6 | Nicholls, D. G., Sihra, T. S. and Sanchez-Prieto, J. (1987) Calciumdependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J. Neurochem. 49, 50-57. DOI |
7 | Ohyama, A., Hosaka, K., Komiya, Y., Akagawa, K., Yamauchi, E., Taniguchi, H., Sasagawa, N., Kumakura, K., Mochida, S., Yamauchi, T. and Igarashi, M. (2002) Regulation of exocytosis through Ca2+/ATP-dependent binding of autophosphorylated Ca2+/calmodulinactivated protein kinase II to syntaxin 1A. J. Neurosci. 22, 3342-3351. DOI |
8 | Mdzinarishvili, A., Sumbria, R., Lang, D. and Klein, J. (2012) Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. J. Pharm. Pharm. Sci. 15, 94-102. DOI |
9 | Rehman, M. U., Wali, A. F., Ahmad, A., Shakeel, S., Rasool, S., Ali, R., Rashid, S. M., Madkhali, H., Ganaie, M. A. and Khan, R. (2019) Neuroprotective strategies for neurological disorders by natural products: an update. Curr. Neuropharmacol. 17, 247-267. DOI |
10 | Tibbs, G. R., Barrie, A. P., Van Mieghem, F. J., McMahon, H. T. and Nicholls, D. G. (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J. Neurochem. 53, 1693-1699. DOI |
11 | Obrenovitch, T. P. and Urenjak, J. (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51, 39-87. DOI |
12 | Hinds, H. L., Goussakov, I., Nakazawa, K., Tonegawa, S. and Bolshakov, V. Y. (2003) Essential function of alpha-calcium/calmodulin-dependent protein kinase II in neurotransmitter release at a glutamatergic central synapse. Proc. Natl. Acad. Sci. U.S.A. 100, 4275-4280. DOI |
13 | Berridge, M. J. (1998) Neuronal calcium signaling. Neuron 21, 13-26. DOI |
14 | Hudmon, A. and Schulman, H. (2002) Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu. Rev. Biochem. 71, 473-510. DOI |
15 | Lee, C. W., Lin, Z. C., Hsu, L. F, Fang, J. Y., Chiang, Y. C., Tsai, M. H., Lee, M. H., Li, S. Y., Hu, S. C., Lee, I. T. and Yen, F. L. (2016) Eupafolin ameliorates COX-2 expression and PGE2 production in particulate pollutants-exposed human keratinocytes through ROS/MAPKs pathways. J. Ethnopharmacol. 189, 300-309. DOI |
16 | Abbasi, A. M., Khan, M. A., Ahmad, M., Zafar, M., Jahan, S. and Sultana, S. (2010) Ethnopharmacological application of medicinal plants to cure skin diseases and in folk cosmetics among the tribal communities of North-West Frontier Province, Pakistan. J. Ethnopharmacol. 128, 322-335. DOI |
17 | Akerman, K. E., Scott, I. G., Heikkila, J. E. and Heinonen, E. (1987) Ionic dependence of membrane potential and glutamate receptorlinked responses in synaptoneurosomes as measured with a cyanine dye, DiS-C2-(5). J. Neurochem. 48, 552-559. DOI |
18 | Chang, Y., Lu, C. W., Lin, T. Y., Huang, S. K. and Wang, S. J. (2016) Baicalein, a constituent of Scutellaria baicalensis, reduces glutamate release and protects neuronal cell against kainic acid-induced excitotoxicity in rats. Am. J. Chinese Med. 44, 943-962. DOI |
19 | Chen, X., Yao, Z., Peng, X., Wu, L., Wu , H., Ou, Y. and Lai, J. (2020) Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF κB signaling pathway. Mol. Med. Rep. 22, 5135-5144. DOI |
20 | Chi, P., Greengard, P. and Ryan, T. A. (2003) Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 38, 69-78. DOI |
21 | Ko, H. H., Chiang, Y. C., Tsai, M. H., Liang, C. J., Hsu, L. F., Li, S. Y., Wang, M. C., Yen, F.L., and Lee, C. W. (2014) Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: role of MAPK and Akt pathways. J. Ethnopharmacol. 151, 386-393. DOI |
22 | Lewerenz, J. and Maher, P. (2015) Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front. Neurosci. 9, 469. DOI |
23 | Baldwin, M. L., Rostas, J. A. and Sim, A. T. (2003) Two modes of exocytosis from synaptosomes are differentially regulated by protein phosphatase types 2A and 2B. J. Neurochem. 85, 1190-1199. DOI |
24 | Bano, D. and Ankarcrona, M. (2018) Beyond the critical point: an overview of excitotoxicity, calcium overload and the downstream consequences. Neurosci. Lett. 663, 79-85. DOI |
25 | Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634. DOI |
26 | Llinas, R., Gruner, J. A., Sugimori, M., McGuinness, T. L. and Greengard, P. (1991) Regulation by synapsin I and Ca2+-calmodulin-dependent protein kinase II of the transmitter release in squid giant synapse. J. Physiol. 436, 257-282. DOI |
27 | Lazarevic, V., Yang, Y., Ivanova, D., Fejtova, A., and Svenningsson, P. (2018) Riluzole attenuates the efficacy of glutamatergic transmission by interfering with the size of the readily releasable neurotransmitter pool. Neuropharmacology 143, 38-48. DOI |
28 | Leon, D., Sanchez-Nogueiro, J., Marin-Garcia, P. and Miras-Portugal, M. A. (2008) Glutamate release and synapsin-I phosphorylation induced by P2X7 receptors activation in cerebellar granule neurons. Neurochem. Int. 52, 1148-1159. DOI |
29 | Vazquez, E. and Sanchez-Prieto, J. (1997) Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur. J. Neurosci. 9, 2009-2018. DOI |
30 | Wang, Z. W. (2008) Regulation of synaptic transmission by presynaptic CaMKII and BK channels. Mol. Neurobiol. 38, 153-166. DOI |
31 | Leenders, A. G. and Sheng, Z. H. (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol. Ther. 105, 69-84. DOI |
32 | Murthy, V. N. (1999) Optical detection of synaptic vesicle exocytosis and endocytosis. Curr. Opin. Neurobiol. 9, 314-320. DOI |
33 | Wong, S. B., Cheng, S. J., Hung, W. C., Lee, W. T. and Min, M. Y. (2015) Rosiglitazone suppresses in vitro seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy. PLoS ONE 10, e0144806. DOI |
34 | Zhou, Y. and Danbolt, N. C. (2014) Glutamate as a neurotransmitter in the healthy brain. J. Neural Transm. (Vienna) 121, 799-817. DOI |
35 | Zhang, H., Chen, M. K., Li, K., Hu, C., Lu, M. H. and Situ, J. (2017) Eupafolin nanoparticle improves acute renal injury induced by LPS through inhibiting ROS and inflammation. Biomed. Pharmacother. 85, 704-711. DOI |
36 | Parvez, M. K. (2018) Natural or plant products for the treatment of neurological disorders: current knowledge. Curr. Drug Metab. 19, 424-428. DOI |
37 | Lin, F. J., Yen, F. L., Chen, P. C., Wang, M. C., Lin, C. N., Lee, C. W. and Ko, H. H. (2014) HPLC-fingerprints and antioxidant constituents of Phyla nodiflora. Sci. World J. 2014, 528653. |
38 | Lin, Z. C., Lee, C. W., Tsai, M. H., Ko, H. H., Fang, J. Y., Chiang, Y. C., Liang, C.J., Hsu, L.F., Hu, S.C.S. and Yen, F. L. (2016) Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress. Int. J. Nanomedicine 11, 3907-3926. DOI |
39 | Lu, C. W., Hung, C. F., Lin, T. Y., Hsieh, T. Y. and Wang, S. J. (2019) Allicin inhibits glutamate release from rat cerebral cortex nerve terminals through suppressing Ca(2+) influx and protein kinase C activity. J. Med. Food 22, 696-702. DOI |
40 | McEntee, W. J. and Crook, T. H. (1993) Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology (Berl.) 111, 391-401. DOI |
41 | Nichols, R. A., Sihra, T. S., Czernik, A. J., Nairn, A. C. and Greengard, P. (1990) Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature 343, 647-651. DOI |
42 | Barrie, A. P., Nicholls, D. G., Sanchez-Prieto, J. and Sihra, T. S. (1991) An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J. Neurochem. 57, 1398-1404. DOI |